Broadly altered expression of the mRNA isoforms of FE65, a facilitator of beta amyloidogenesis, in Alzheimer cerebellum and other brain regions
- 16 March 2000
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
Abstract
FE65 is a key “adapter” protein that links a multiprotein complex to an intracellular domain of β-amyloid precursor protein (βPP). Its overexpression modulates the trafficking of βPP and facilitates the generation of β-amyloid (Aβ). FE65 is predominantly expressed in brain tissues. An exon 9-inclusive isoform is exclusively expressed in neurons, and an exon 9-exclusive isoform is only expressed in non-neuronal cells. We quantitated the two isoforms in middle temporal cortex, middle frontal cortex, cerebellar cortex and caudate nucleus of 17 Alzheimer disease (AD) patients, 12 normal controls and 9 non-AD neurodegenerative disease controls by reverse transcription-competitive polymerase chain reaction (RT-cPCR). Expression of the two isoforms was significantly and differentially altered, with a 30–57% decrease in levels of the neuronal form (P < 0.05–0.002) and a 73–135% increase in levels of non-neuronal form (P < 0.02–0.001), in the temporal and frontal cortex of AD brains. These alterations presumably reflect advanced neurodegenerative processes of these regions. Surprisingly, expression of both isoforms was significantly up-regulated by 42–66% in the cerebellar cortex and caudate nucleus of AD brains when compared to normal brains (P < 0.05–0.005). Diffuse Aβ-positive plaques were observed in the cerebellum of these AD subjects but not in the normal controls. Selective up-regulation of only the FE65 neuronal isoform was seen in the cerebellar cortex in association with other neurodegenerative diseases (largely Parkinson's disease). Because FE65 modulates trafficking of βPP toward the production of Aβ, the up-regulation of FE65 in AD cerebellum may be relevant to the genesis of diffuse plaques. Thus, early biochemical alterations in AD, not complicated by advanced pathology, may be beneficially investigated in the less-affected regions of the brain, such as the cerebellum. J. Neurosci. Res. 60:73–86, 2000Keywords
This publication has 50 references indexed in Scilit:
- Frequency of Stages of Alzheimer-Related Lesions in Different Age CategoriesNeurobiology of Aging, 1997
- The Phosphotyrosine Interaction Domains of X11 and FE65 Bind to Distinct Sites on the YENPTY Motif of Amyloid Precursor ProteinMolecular and Cellular Biology, 1996
- cDNA cloning and chromosome mapping of the human Fe65 gene: interaction of the conserved cytoplasmic domains of the human beta-amyloid precursor protein and its homologues with the mouse Fe65 proteinHuman Molecular Genetics, 1996
- Morphometric Analysis of Microglia in Alzheimerʼs DiseaseJournal of Neuropathology and Experimental Neurology, 1993
- Study of the synthesis and secretion of normal and artificial mutants of murine amyloid precursor protein (APP): cleavage of APP occurs in a late compartment of the default secretion pathway.The Journal of cell biology, 1993
- Adenylyl Cyclase Activity in Postmortem Human Brain: Evidence of Altered G Protein Mediation in Alzheimer's DiseaseJournal of Neurochemistry, 1992
- Selective reduction of quisqualate (AMPA) receptors in Alzheimer cerebellumAnnals of Neurology, 1990
- Alzheimer's disease: amyloid plaques in the cerebellumJournal of the Neurological Sciences, 1989
- Neuron numbers and dendritic extent in normal aging and Alzheimer's diseaseNeurobiology of Aging, 1987
- Alzheimer's disease: Choline acetyltransferase activity in brain tissue from clinical and pathological subgroupsAnnals of Neurology, 1983